Palvella Therapeutics (PVLA) Cash & Current Investments (2016 - 2024)
Historic Cash & Current Investments for Palvella Therapeutics (PVLA) over the last 12 years, with Q3 2024 value amounting to $14.2 million.
- Palvella Therapeutics' Cash & Current Investments fell 7495.06% to $14.2 million in Q3 2024 from the same period last year, while for Sep 2024 it was $14.2 million, marking a year-over-year decrease of 7495.06%. This contributed to the annual value of $16.3 million for FY2023, which is 7241.8% down from last year.
- As of Q3 2024, Palvella Therapeutics' Cash & Current Investments stood at $14.2 million, which was down 7495.06% from $14.5 million recorded in Q2 2024.
- Palvella Therapeutics' Cash & Current Investments' 5-year high stood at $125.1 million during Q3 2021, with a 5-year trough of $6.2 million in Q1 2024.
- Over the past 5 years, Palvella Therapeutics' median Cash & Current Investments value was $70.4 million (recorded in 2020), while the average stood at $68.8 million.
- Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 6719.29% in 2021, then plummeted by 8904.57% in 2024.
- Quarter analysis of 5 years shows Palvella Therapeutics' Cash & Current Investments stood at $70.4 million in 2020, then skyrocketed by 67.19% to $117.8 million in 2021, then plummeted by 49.76% to $59.2 million in 2022, then crashed by 72.42% to $16.3 million in 2023, then decreased by 12.95% to $14.2 million in 2024.
- Its Cash & Current Investments stands at $14.2 million for Q3 2024, versus $14.5 million for Q2 2024 and $6.2 million for Q1 2024.